Morphic Holding, Inc. (MORF) Financial Statements (2024 and earlier)

Company Profile

Business Address 35 GATEHOUSE DRIVE A2
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments59,272171,434228,264237,016
Cash and cash equivalents59,272171,434102,047101,559
Short-term investments   126,217135,457
Receivables 4552,3077,3143,467
Other undisclosed current assets302,455244,5933,8573,090
Total current assets:362,182418,334239,435243,573
Noncurrent Assets
Operating lease, right-of-use asset3,5144,806  
Property, plant and equipment2,1192,5832,6063,446
Other noncurrent assets214766141
Other undisclosed noncurrent assets560560275275
Total noncurrent assets:6,4077,9562,9473,862
TOTAL ASSETS:368,589426,290242,382247,435
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:13,18112,83810,1606,639
Employee-related liabilities6,3965,1483,159
Accounts payable3,4754,7983,845 
Accrued liabilities8539636771,015
Other undisclosed accounts payable and accrued liabilities8,8536814902,465
Deferred revenue 47020,62825,26623,450
Deferred rent credit   16794
Other undisclosed current liabilities3,4754,7983,8455,167
Total current liabilities:17,12638,26439,43835,350
Noncurrent Liabilities
Long-term debt and lease obligation:  3,838  
Liabilities, other than long-term debt2,34447,48957,74771,167
Deferred revenue  47,48957,67270,954
Deferred rent credit   75213
Operating lease, liability2,3443,838  
Total noncurrent liabilities:2,34451,32757,74771,167
Total liabilities:19,47089,59197,185106,517
Equity
Equity, attributable to parent349,119336,699145,197140,918
Common stock4433
Additional paid in capital649,549575,231287,727238,384
Accumulated other comprehensive income (loss)(3,339)(482)(21)44
Accumulated deficit(297,095)(238,054)(142,512)(97,513)
Total equity:349,119336,699145,197140,918
TOTAL LIABILITIES AND EQUITY:368,589426,290242,382247,435

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues70,80819,79444,94516,977
Gross profit:70,80819,79444,94516,977
Operating expenses(134,204)(115,600)(92,125)(63,965)
Operating loss:(63,396)(95,806)(47,180)(46,988)
Nonoperating income4,4222641,6114,572
Other nonoperating income (expense)(145)(8)1,6114,572
Loss from continuing operations before income taxes:(58,974)(95,542)(45,569)(42,416)
Income tax expense (benefit)(67) 570(912)
Loss from continuing operations:(59,041)(95,542)(44,999)(43,328)
Loss before gain (loss) on sale of properties:(95,542)(44,999)(43,328)
Net loss available to common stockholders, diluted:(59,041)(95,542)(44,999)(43,328)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(59,041)(95,542)(44,999)(43,328)
Other comprehensive income (loss)(2,857)(461)(65)44
Comprehensive loss, net of tax, attributable to parent:(61,898)(96,003)(45,064)(43,284)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: